Calyxt, Inc. (NASDAQ:CLXT) had its target price raised by Wells Fargo & Company from $17.00 to $30.00 in a research report sent to investors on Friday. Wells Fargo & Company currently has an outperform rating on the stock.

CLXT has been the subject of several other reports. Citigroup Inc. started coverage on shares of Calyxt in a research report on Tuesday, August 15th. They set a buy rating and a $16.00 target price on the stock. Jefferies Group LLC started coverage on shares of Calyxt in a research note on Monday, August 14th. They issued a buy rating and a $16.00 target price on the stock.

Calyxt (NASDAQ CLXT) opened at 26.40 on Friday. The firm’s market cap is $517.44 million. Calyxt has a 52-week low of $9.26 and a 52-week high of $29.45. The firm has a 50-day moving average of $20.16 and a 200 day moving average of $17.98.

TRADEMARK VIOLATION WARNING: This piece was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.watchlistnews.com/calyxt-inc-clxt-price-target-increased-to-30-00-by-analysts-at-wells-fargo-company/1604291.html.

Calyxt Company Profile

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Receive News & Ratings for Calyxt Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.